- HEALWELL has signed a multi-million dollar, multi-year U.S.-based Health Information Exchange (HIE) software contract following a competitive procurement process.
- Strong momentum in all parts of the software pipeline including renewals, extensions, short listing and intent to award have advanced across core markets, reinforcing recurring data infrastructure revenue.
- Increasing participation in coordinated, enterprise-scale RFP bids leveraging Orion Health's global footprint.
Toronto, Ontario--(Newsfile Corp. - March 5, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, today provides a strategic update on its Software Business Unit, reflecting continued infrastructure expansion, renewal momentum and advancing AI integration across its global platform.
Expansion and U.S. HIE Contract
HEALWELL's software division has signed a multi-million dollar U.S.-based Health Information Exchange (HIE) software contract following a competitive procurement process, expanding the Company's enterprise data interoperability footprint in the world's largest healthcare market. The contract will support the secure aggregation and exchange of healthcare data for millions of patient lives, connecting multiple hospital systems, clinics, laboratories, public health agencies and community providers across a U.S. state. By aggregating and normalizing clinical data from disparate systems, the platform delivers timely admission, discharge, and transfer alerts, lab results, care summaries, and other critical records directly into provider workflows. This will improve care coordination, reduce duplication, support population health and public health reporting, and ensure clinicians have a more complete view of a patient's health history at the point of care.
This contract win followed a coordinated bid effort across the Company's Orion Health and VeroSource businesses, with HEALWELL selected based on its proven ability to deliver large-scale HIE infrastructure, manage complex and fragmented healthcare data environments, and execute successfully at state- and nation-wide scale, with integrated AI capabilities that could further strengthen the platform over time. This award reinforces HEALWELL's position as a provider of critical digital health infrastructure supporting secure, large-scale data aggregation and exchange.
In parallel, HEALWELL's software division continues to gain momentum across all stages of the software pipeline, including existing customer extensions and bidding on new opportunities, across Canada, the Middle East, Europe and other core jurisdictions, supporting recurring revenue visibility and long-term customer relationships.
Dr. Alexander Dobranowski, President of HEALWELL AI, commented, "The progress in our software division is exciting to see. We recently updated the market on the benefits the Orion distribution network is having on our AI and data science sales pipeline, so it is very pleasing to see how that positive momentum is also driving demand in our software division. As we advance renewals and expand coordinated bid activity, we are building a strong foundation for long-term growth across the United States, Canada, the Middle East and other key markets."
AI Integration Across the Orion Amadeus Platform
HEALWELL has integrated its SMART Identify, SMART Search and SMART Summary capabilities into the Amadeus AI platform, creating a unified infrastructure-and-AI offering. These AI modules are clear differentiators and are driving the pipeline growth across both existing and new healthcare environments in the United States, Canada and the Middle East, enabling improved patient identification, intelligent data retrieval and clinical summarization within live interoperability networks.
This builds on recent deployments and success stories, including HEALWELL's first AI contract with a major governmental health system in the Middle East; active deployments of SMART Identify in the United States, and deployment of SMART Search and SMART Summary in a provincial healthcare system in Canada.
The integration of clinically validated AI directly into the Orion platform strengthens the Company's competitive positioning, enhances data liquidity across HEALWELL's distribution network and creates scalable pathways for enterprise AI commercialization.
Integrated Bid Strategy and Enterprise-Scale Opportunities
HEALWELL continues to pursue larger and more strategic procurement opportunities through coordinated bids that leverage capabilities across its software portfolio. Orion Health's global footprint is enabling the Company to compete for enterprise-scale programs that combine interoperability, analytics and AI-enabled workflows.
The Company reports growing participation in multi-capability bids across North America and international markets, reflecting increasing demand for integrated infrastructure and AI solutions within healthcare systems.
Brad Porter, Chief Commercial Officer of HEALWELL AI, commented, "Our strategy was to build two key levers of growth for our company. The Company's recent progress is validating that HEALWELL can both drive expansion of our AI solutions through the Orion distribution network and expand our distribution network through a differentiated product set. We are demonstrating the power of integrating durable interoperability infrastructure with clinically validated AI. We believe the practical application of AI has the most potential impact on Healthcare IT, and that HEALWELL is demonstrating that rather than being a headwind for our sector, it is a clear tailwind."
James Lee
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
Forward-Looking Statements
Certain statements in this press release, constitute "forward-looking information" and "forward looking statements" (collectively, "forward looking statements") within the meaning of applicable Canadian securities laws, including statements about the Company's recently executed HIE software contract and its potential benefits, value and timeline for performance; momentum perceived in the Company's software pipeline; the Company's participation in multi-capability bids; and continued advancement in AI integration across the Company's product and service offerings; and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as "momentum", "increasing", "pipeline", "short listing", "intent to award", "continuing", "advancing", "expanding", "building", "expected", "opportunities", "growing", "enabling", or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms. Forward-looking statements are necessarily based upon management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: HEALWELL's ability to perform its obligations under the HIE contract and the quality and service levels which it will be able to deliver under it; HEALWELL's ability to maintain and leverage its relationships with its commercial partners; HEALWELL's ability to secure and successfully conclude negotiations over bids, renewals, short-listings and intents to award and the terms on which final agreements can be executed; the continued adoption of the software, tools and solutions created by HEALWELL and its subsidiaries; the stability of general economic and market conditions; sufficiency of working capital and access to financing; HEALWELL's ability to comply with applicable laws and regulations; HEALWELL's continued compliance with third party intellectual property rights; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; technologies working as intended or at all; trends in customer growth and the adoption of new technologies in the industry; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.
Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in HEALWELL's most recent annual information form dated March 31, 2025, which is available under HEALWELL's SEDAR+ profile at www.sedarplus.ca. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
For more information:
Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
ir@healwell.ai
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286268
Source: HEALWELL AI
